Prot#EDP 305-102: A Phase 2b Randomized, Double Blind, Placebo-Controlled, Multicenter Study Evaluating Safety and Efficacy of EDP-305 in Subjects with Liver-Biopsy Proven Non-Alcoholic Steatohepatitis (NASH)”

Project: Research project

Project Details

StatusActive
Effective start/end date7/31/207/31/23

Funding

  • ICON Clinical Research, LLC (Prot#EDP 305-102)
  • Enanta Pharmaceuticals, Inc. (Prot#EDP 305-102)